Explore: Biotech · Drug Discovery · Diagnostics · Digital Health · Seed
Cancer Breakthrough Fund
Lumira Ventures
The Cancer Breakthrough Fund is a partnership between Lumira Ventures and the Terry Fox Foundation designed to invest in mission-driven companies developing novel cancer therapies. The fund bridges philanthropic capital with venture expertise to support oncology innovation across preclinical, clinical, and commercial stages.
Cancer Breakthrough Fund (Lumira Ventures) invests at seed, focuses on Biotech, Drug Discovery, Diagnostics, Digital Health and Medtech, backs founders in Canada.
Stages
Sectors
Geographies
Headquarters
Canada
🔒 Team & partners
Sign in to view🔒 Live funding signals
Sign in to view🔒 Contacts
Sign in to viewSign in to see Cancer Breakthrough Fund's full profile
Team & partners, portfolio, live funding signals and contacts. Free account, Google sign-in.
Create free accountVerified 5 May 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does Cancer Breakthrough Fund invest in?
- Cancer Breakthrough Fund invests in Biotech, Drug Discovery, Diagnostics, Digital Health and Medtech at the seed stage.
- Which geographies does Cancer Breakthrough Fund focus on?
- Cancer Breakthrough Fund focuses on Canada, and is headquartered in Canada.